BSX vs ITGR
BSX: Boston Scientific is a leading medical device company dedicated to transforming lives through innovative, less-invasive medical solutions for a broad range of interventional specialties. ITGR: Integer Holdings is a leading medical device outsource manufacturer supplying critical components and complex assemblies to global OEMs in the cardiac and neuromodulation sectors.
Side-by-side fundamentals
| Metric | BSX | ITGR | Edge |
|---|---|---|---|
| Price as of 2026-08-24 close | $49.01 | $125.07 | |
| Market cap as of 2026-08-24 | $71.0B | $4.3B | |
| P/E as of 2026-08-24 | 19.87 | 34.08 | BSX lower |
| PEG as of 2026-08-24 | 0.43 | 0.55 | BSX lower |
| Net margin as of 2026-08-24 | +17.5% | +7.0% | BSX higher |
| Gross margin as of 2026-08-24 | +69.5% | +26.1% | BSX higher |
| Operating margin as of 2026-08-24 | +19.8% | +9.7% | BSX higher |
| ROE as of 2026-08-24 | +14.9% | +7.4% | BSX higher |
| ROA as of 2026-08-24 | +8.3% | +3.8% | BSX higher |
| Debt / equity as of 2026-08-24 | 0.51 | 0.75 | BSX lower |
| Revenue growth (YoY) as of 2026-08-24 | +13.5% | +2.7% | BSX higher |
| Revenue CAGR (3y) SEC XBRL | +16.5% | +11.7% | BSX higher |
| Dividend yield | n/a | n/a | |
| Beta as of 2026-08-24 | 0.58 | 0.79 | |
| 1-year return as of 2026-08-24 close | -53.8% | +13.1% | ITGR higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.